Quick Answer
CareDx, Inc. reported Total Revenue of $379.81 million for fiscal year 2025.
CareDx, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $379.81M +13.8% |
$333.79M +19.1% |
$280.32M -12.9% |
$321.79M +8.6% |
$296.40M +54.2% |
$192.19M +51.3% |
| Revenue (ASC 606) | $379.81M +13.8% |
$333.79M +19.1% |
$280.32M -12.9% |
$321.79M +8.6% |
$296.40M +54.2% |
$192.19M +51.3% |
| Net Income | -$21.35M -140.6% |
$52.55M +127.6% |
-$190.28M -148.4% |
-$76.61M -149.9% |
-$30.66M -63.8% |
-$18.71M +14.8% |
| Diluted EPS | -$0.40 -143.0% |
$0.93 +126.3% |
-$3.54 -145.8% |
-$1.44 -144.1% |
-$0.59 -47.5% |
-$0.40 +23.1% |
| Total Assets | $413.23M -15.8% |
$491.05M +5.2% |
$466.83M -14.0% |
$542.99M -4.2% |
$566.62M +53.8% |
$368.51M +142.9% |
| Cash and Equivalents | $65.43M -43.0% |
$114.69M +39.5% |
$82.20M -8.6% |
$89.92M -74.2% |
$348.49M +158.8% |
$134.67M +252.3% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $303.10M -19.9% |
$378.43M +44.8% |
$261.33M -39.4% |
$430.91M -7.5% |
$465.88M +67.8% |
$277.68M +180.5% |
| R&D Expense | $71.43M -1.5% |
$72.51M -12.0% |
$82.42M -8.8% |
$90.39M +18.1% |
$76.53M +56.4% |
$48.94M +59.4% |
| Operating Income | -$30.78M -175.5% |
$40.77M +120.0% |
-$203.36M -163.3% |
-$77.23M -159.8% |
-$29.73M -32.0% |
-$22.53M +8.2% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 50.92M -7.0% |
54.77M +6.3% |
51.50M -3.8% |
53.53M +1.2% |
52.92M +7.0% |
49.44M +16.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $100.06M | +20.7% | +15.4% |
| Revenue (ASC 606) | September 30, 2025 | $100.06M | +20.7% | +15.4% |
| Net Income | September 30, 2025 | $1.68M | +115.7% | +119.5% |
| Diluted EPS | September 30, 2025 | $0.03 | +115.0% | +118.8% |
| Total Assets | September 30, 2025 | $432.31M | -9.4% | -2.7% |
| Cash and Equivalents | September 30, 2025 | $91.44M | -4.2% | +34.0% |
| Long-Term Debt | September 30, 2018 | $13.38M | -36.8% | +0.4% |
| Stockholders Equity | September 30, 2025 | $311.14M | +13.9% | -5.0% |
| R&D Expense | September 30, 2025 | $16.77M | -4.1% | -0.4% |
| Operating Income | September 30, 2025 | -$246.0K | +98.2% | +97.8% |
| Gross Profit | June 30, 2020 | $26.78M | +34.3% | +3.0% |
| Shares Outstanding | September 30, 2025 | 51.41M | -3.2% | -3.4% |
- CareDx, Inc. reported Total Revenue of $379.81 million for fiscal year 2025.
- CareDx, Inc. showed an increase of +13.8% in Total Revenue compared to the prior fiscal year.
- CareDx, Inc. reported Revenue (ASC 606) of $379.81 million for fiscal year 2025.
- CareDx, Inc. showed an increase of +13.8% in Revenue (ASC 606) compared to the prior fiscal year.
- CareDx, Inc. reported Net Income of -$21.35 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -140.6% in Net Income compared to the prior fiscal year.
- CareDx, Inc. reported Diluted EPS of $0.40 per share (loss) for fiscal year 2025.
- CareDx, Inc. showed a decrease of -143.0% in Diluted EPS compared to the prior fiscal year.
- CareDx, Inc. reported Total Assets of $413.23 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -15.8% in Total Assets compared to the prior fiscal year.
- CareDx, Inc. reported Cash and Equivalents of $65.43 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -43.0% in Cash and Equivalents compared to the prior fiscal year.
- CareDx, Inc. reported Long-Term Debt of $0.00 for fiscal year 2018.
- CareDx, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- CareDx, Inc. reported Stockholders Equity of $303.10 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -19.9% in Stockholders Equity compared to the prior fiscal year.
- CareDx, Inc. reported R&D Expense of $71.43 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -1.5% in R&D Expense compared to the prior fiscal year.
- CareDx, Inc. reported Operating Income of -$30.78 million for fiscal year 2025.
- CareDx, Inc. showed a decrease of -175.5% in Operating Income compared to the prior fiscal year.
- CareDx, Inc. reported Gross Profit of $81.61 million for fiscal year 2019.
- CareDx, Inc. showed an increase of +87.3% in Gross Profit compared to the prior fiscal year.
- CareDx, Inc. reported Shares Outstanding of 50.92 million shares for fiscal year 2025.
- CareDx, Inc. showed a decrease of -7.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: